Table II. Histone deacetylase inhibitors and their action against triple-negative breast cancer.

HDAC: Histone deacetylases; SAHA: suberoylanilidehydroxamic acid; NaB: sodium butyrate; YCW1: [3-(2-(5-methoxy-1H-indol-1yl)ethoxy)phenyl]-amide N-hydroxyamide; IR: ionizing radiation; TSA: trichostatin A; ATRA: all-trans retinoic acid; EMT: epithelial tomesenchymal transition; FOXA1; forkhead-box protein A1; G6PDH: glucose-6phosphate dehydrogenase; CDH1: cadherin; ERa: estrogen receptora; ALDH1: aldehyde dehydrogenase 1; TopoII-β: topoisomerase II-β; RAR-β: retinoic acid receptor; BNIP3: BCL2/adenovirus E1B 19 kDa proteininteracting protein 3.